Nyheter ifrån Redeye

Redeye assisting InDex Pharmaceutical in private placement

News 2010-12

In December 2010, Redeye placed 25 percent of the outstanding shares in InDex Pharmaceutical on two private investors.

InDex Pharmaceuticals develops innovative drugs for the treatment of diseases within a variety of therapeutic areas, including inflammation and cancer.

For more information, contact:
Richard Goldman, Head of Corporate Finance
+46 761 84 11 11
richard.goldman@redeye.se

 

About Redeye
Redeye AB is a specialist investment banking boutique that focuses on small and mid-cap growth companies in the Nordic region. We focus on the IT, life sciences, media, betting, clean tech and commodities sectors. We provide services within Corporate Broking, Corporate Finance, equity research, investor relations and media services. Our strengths are our award-winning research and analysis department, experienced advisers, a unique investor network, and powerful distribution channel redeye.se. Redeye was founded in 1999 and since 2007 has been subject to the supervision of the Swedish Financial Supervisory Authority.


Fler nyheter ifrån Redeye

Publiceringsdatum Titel
2012-02-21 BioInvent - Rights issue
2012-02-21 Capilon - Public offer
2012-02-06 Vd-byte på Redeye
2012-02-02 Redeye inleder analysbevakning av Caperio Holding
2012-01-23 Redeyes Life Science-favoriter för 2012
2011-11-30 Redeye advising Arctic Gold in SEK 10.5m private placement
2011-11-23 Redeye arranged IT-seminar with 15 presenting companies
2011-11-08 Redeye in cooperation with Nordnet arranged Börsdagarna
2011-10-13 Redeye arranged themed betting event focused on legal risks in the business
2011-10-06 Redeye arranged Exploration & Mining Seminar with 6 presenting companies
2011-07-15 Richard Goldman joins Redeye as Head of Corporate Finance
2011-07-01 Redeye advising Mintage Scientific AB in SEK 12m rights offering
2011-06-01 Redeye assisting in block transaction in Hansa Medical and Genovis
2011-05-26 Redeye in cooperation with Avanza arranged Börsdagarna
2011-05-01 Redeye assisting Moberg Derma in IPO
2011-04-01 Redeye assisting in private placement in Lociloci
2011-04-01 Redeye assisting in private placement in Connected Tables
2011-01-21 Redeyes fem IT-favoriter för 2011
2011-01-01 Redeye advising the divestment of allabolag.se
2011-01-01 Magnus Vestin joins Redeye as Director at Redeye Corporate Finance
2010-12-01 Redeye assisting InDex Pharmaceutical in private placement
2010-11-30 Redeye AB rådgivare åt Farstorp Invest i samband med offentligt bud på Biolin Scientific
2010-11-10 Sveriges första aktieanalys-app för din iPhone
2010-10-31 Samarbetet mellan Redeye och Tanglin upphör